Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization

We demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function. First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro, and rHMGB1-activated DCs prime naïve lymphocytes to produ...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Zhang, Gang Huang, Bo Hu, Li-Ping Fang, E-Hong Cao, Xiao-Feng Xin, Yong Song, Yi Shi
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/257930
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563693724893184
author Fang Zhang
Gang Huang
Bo Hu
Li-Ping Fang
E-Hong Cao
Xiao-Feng Xin
Yong Song
Yi Shi
author_facet Fang Zhang
Gang Huang
Bo Hu
Li-Ping Fang
E-Hong Cao
Xiao-Feng Xin
Yong Song
Yi Shi
author_sort Fang Zhang
collection DOAJ
description We demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function. First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro, and rHMGB1-activated DCs prime naïve lymphocytes to produce the Th17 cytokine IL-17A. Second, we demonstrate that anti-HMGB1 neutralizing antibody attenuates HMGB1 expression, neutrophilic inflammation, airway hyperresponsiveness, and Th17-related cytokine secretion in vivo by using a murine model of neutrophilic asthma induced by ovalbumin (OVA) plus lipopolysaccharide (LPS). Furthermore, anti-HMGB1 neutralizing antibody decreases the number of Th17 cells in lung cells and suppresses the production of IL-23 by lung CD11C+ APCs. Finally, we show that intranasal adoptive transfer of rHMGB1-activated DCs was sufficient to restore lung neutrophilic inflammation and the Th17 response in a DC-driven model of asthma, whereas the transfer of rHMGB1 plus anti-HMGB1-treated mDCs significantly reduced these inflammation phenotypes. These data suggest, for the first time, that HMGB1 drives the DC-polarized Th17-type response in allergic lung inflammation and that blocking HMGB1 may benefit the attenuation of neutrophilic airway inflammation in asthma.
format Article
id doaj-art-306eb52445be4e57914fed174aefa1c7
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-306eb52445be4e57914fed174aefa1c72025-02-03T01:12:48ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/257930257930Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 PolarizationFang Zhang0Gang Huang1Bo Hu2Li-Ping Fang3E-Hong Cao4Xiao-Feng Xin5Yong Song6Yi Shi7Department of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaDepartment of Medical Genetics, Third Military Medical University, Chongqing 430038, ChinaDepartment of Administration, 105 Hospital, Hefei 230031, ChinaDepartment of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaDepartment of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaDepartment of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaDepartment of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaDepartment of Pulmonary Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, ChinaWe demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function. First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro, and rHMGB1-activated DCs prime naïve lymphocytes to produce the Th17 cytokine IL-17A. Second, we demonstrate that anti-HMGB1 neutralizing antibody attenuates HMGB1 expression, neutrophilic inflammation, airway hyperresponsiveness, and Th17-related cytokine secretion in vivo by using a murine model of neutrophilic asthma induced by ovalbumin (OVA) plus lipopolysaccharide (LPS). Furthermore, anti-HMGB1 neutralizing antibody decreases the number of Th17 cells in lung cells and suppresses the production of IL-23 by lung CD11C+ APCs. Finally, we show that intranasal adoptive transfer of rHMGB1-activated DCs was sufficient to restore lung neutrophilic inflammation and the Th17 response in a DC-driven model of asthma, whereas the transfer of rHMGB1 plus anti-HMGB1-treated mDCs significantly reduced these inflammation phenotypes. These data suggest, for the first time, that HMGB1 drives the DC-polarized Th17-type response in allergic lung inflammation and that blocking HMGB1 may benefit the attenuation of neutrophilic airway inflammation in asthma.http://dx.doi.org/10.1155/2014/257930
spellingShingle Fang Zhang
Gang Huang
Bo Hu
Li-Ping Fang
E-Hong Cao
Xiao-Feng Xin
Yong Song
Yi Shi
Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
Mediators of Inflammation
title Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
title_full Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
title_fullStr Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
title_full_unstemmed Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
title_short Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
title_sort anti hmgb1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell mediated th17 polarization
url http://dx.doi.org/10.1155/2014/257930
work_keys_str_mv AT fangzhang antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT ganghuang antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT bohu antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT lipingfang antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT ehongcao antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT xiaofengxin antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT yongsong antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization
AT yishi antihmgb1neutralizingantibodyamelioratesneutrophilicairwayinflammationbysuppressingdendriticcellmediatedth17polarization